About Variad Diagnostics

About company

VariAD developed a unique patent-pending test to detect pre-disposition for Crohn’s Disease. The test, code named – deNoVA, analyzes the genetic makeup of the patient and determines the likelihood of the patient to develop Crohn’s as well as the severity level of the pre-disposition. Since this is a genetic test, samples are extracted from the patient through a simple, non-invasive procedure. Evaluated by an independent panel using clinical data, the deNoVa tool demonstrated high-accuracy, correctly identifying 96% of Crohn's patients based on their genome data alone.